Literature DB >> 15286797

Pulmonary fibrosis: thinking outside of the lung.

Stavros Garantziotis1, Mark P Steele, David A Schwartz.   

Abstract

Pulmonary fibrosis is a devastating condition that leads to progressive lung destruction and scarring. Previous mechanistic research has focused on the local fibroproliferative process in the lung. However, emerging evidence suggests that circulating cells of hematopoietic origin play a crucial role in the pathogenesis of this disease.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15286797      PMCID： PMC484986          DOI： 10.1172/JCI22497

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

Review 2.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

3.  Adult familial cryptogenic fibrosing alveolitis in the United Kingdom.

Authors:  R P Marshall; A Puddicombe; W O Cookson; G J Laurent
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

4.  Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.

Authors:  R Bucala; L A Spiegel; J Chesney; M Hogan; A Cerami
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

5.  Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.

Authors:  K B Baumgartner; J M Samet; C A Stidley; T V Colby; J A Waldron
Journal:  Am J Respir Crit Care Med       Date:  1997-01       Impact factor: 21.405

6.  Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis.

Authors:  R Hubbard; S Lewis; K Richards; I Johnston; J Britton
Journal:  Lancet       Date:  1996-02-03       Impact factor: 79.321

Review 7.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

8.  Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.

Authors:  L A Ortiz; J Lasky; R F Hamilton; A Holian; G W Hoyle; W Banks; J J Peschon; A R Brody; G Lungarella; M Friedman
Journal:  Exp Lung Res       Date:  1998 Nov-Dec       Impact factor: 2.459

9.  Susceptibility to asbestos-induced and transforming growth factor-beta1-induced fibroproliferative lung disease in two strains of mice.

Authors:  G Sakuntala Warshamana; Derek A Pociask; Patricia Sime; David A Schwartz; Arnold R Brody
Journal:  Am J Respir Cell Mol Biol       Date:  2002-12       Impact factor: 6.914

10.  Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group.

Authors:  Ronald G Crystal; Peter B Bitterman; Brooke Mossman; Marvin I Schwarz; Dean Sheppard; Laura Almasy; Harold A Chapman; Scott L Friedman; Talmadge E King; Leslie A Leinwand; Lance Liotta; George R Martin; David A Schwartz; Gregory S Schultz; Carston R Wagner; Robert A Musson
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405
View more
  13 in total

1.  Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis.

Authors:  Hiroyuki Higashiyama; Daisuke Yoshimoto; Yuji Okamoto; Hideo Kikkawa; Satoshi Asano; Mine Kinoshita
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

2.  Lung epithelial healing: a modified seed and soil concept.

Authors:  Susan D Reynolds; Heather M Brechbuhl; Mary Kathryn Smith; Russell W Smith; Moumita Ghosh
Journal:  Proc Am Thorac Soc       Date:  2012-05

3.  Contribution of alveolar type II cell-derived cyclooxygenase-2 to basal airway function, lung inflammation, and lung fibrosis.

Authors:  Jennifer Cheng; Ryan T Dackor; J Alyce Bradbury; Hong Li; Laura M DeGraff; Lee K Hong; Debra King; Fred B Lih; Artiom Gruzdev; Matthew L Edin; Gregory S Travlos; Gordon P Flake; Kenneth B Tomer; Darryl C Zeldin
Journal:  FASEB J       Date:  2015-09-22       Impact factor: 5.191

4.  Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis.

Authors:  William R Henderson; Emil Y Chi; Xin Ye; Cu Nguyen; Ying-tzang Tien; Beiyun Zhou; Zea Borok; Darryl A Knight; Michael Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-21       Impact factor: 11.205

5.  Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.

Authors:  Stavros Garantziotis; Enrique Zudaire; Carol S Trempus; John W Hollingsworth; Dianhua Jiang; Lisa H Lancaster; Elizabeth Richardson; Lisheng Zhuo; Frank Cuttitta; Kevin K Brown; Paul W Noble; Koji Kimata; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

6.  Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1.

Authors:  John F Alcorn; Amy S Guala; Jos van der Velden; Brian McElhinney; Charles G Irvin; Roger J Davis; Yvonne M W Janssen-Heininger
Journal:  J Cell Sci       Date:  2008-03-11       Impact factor: 5.285

Review 7.  Ecogenomics of respiratory diseases of public health significance.

Authors:  Stavros Garantziotis; David A Schwartz
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

8.  Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.

Authors:  Jeong Sup Song; Chun Mi Kang; Hyeon Hui Kang; Hyung Kyu Yoon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park
Journal:  Exp Mol Med       Date:  2010-06-30       Impact factor: 8.718

9.  C/EBPβ-Thr217 phosphorylation signaling contributes to the development of lung injury and fibrosis in mice.

Authors:  Martina Buck; Mario Chojkier
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

Review 10.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.

Authors:  Mehrnaz Gharaee-Kermani; Margaret R Gyetko; Biao Hu; Sem H Phan
Journal:  Pharm Res       Date:  2007-03-01       Impact factor: 4.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.